Geovax Labs (GOVX)

Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
March 7, 2024
Report ID: 26577
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Geovax Labs
Geovax Labs
Healthcare
Biotechnology
Ticker
GOVX
Current Price
$1.5 -1.32%
Market Cap
$3.3M
Price Target
Refer to Report
Volume
19.4K
52wk Range
$1.45 - $11.5365
Related Research Reports
3/7/2024

Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation
Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation (GOVX)
3/1/2024

FY2023 Reported With A Review Of Clinical Progress and Upcoming Milestones
FY2023 Reported With A Review Of Clinical Progress and Upcoming Milestones (GOVX)
2/7/2024

Initial Phase 2 Data Shows Immune Responses In COVID-19 Booster Trial
Initial Phase 2 Data Shows Immune Responses In COVID-19 Booster Trial (GOVX)
11/9/2023

3Q23 Quarterly Report Includes 2024 Milestones
3Q23 Quarterly Report Includes 2024 Milestones (GOVX)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.